Compounds > flufenamic acid

flufenamic acid and nadp

flufenamic acid has been researched along with nadp in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gaut, ZN; Solomon, HM1
Machuga, ET; Roth, GJ; Strittmatter, P1
Atalla, A; Breyer-Pfaff, U; Maser, E1
Gopishetty, S; Jin, Y; Oyesanmi, B; Penning, TM; Steckelbroeck, S1
Azzi, A; Ghanmi, D; Labrie, F; Lin, SX; Luu-The, V; Mazumdar, M; Qiu, W; Zhou, M1

Other Studies

5 other study(ies) available for flufenamic acid and nadp

ArticleYear
Inhibition of 7- 14 C-nicotinic acid metabolism in the human blood platelet by anti-inflammatory drugs.
    Research communications in chemical pathology and pharmacology, 1970, Volume: 1, Issue:4

    Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Carbon Isotopes; Depression, Chemical; Flufenamic Acid; Humans; NAD; NADP; Niacinamide; Nicotinic Acids; Ribonucleotides

1970
Reduced pyridine nucleotides and cytochrome b5 as electron donors for prostaglandin synthetase reconstituted in dimyristyl phosphatidylcholine vesicles.
    The Journal of biological chemistry, 1982, Oct-25, Volume: 257, Issue:20

    Topics: Chemical Phenomena; Chemistry; Cytochrome b Group; Cytochrome Reductases; Cytochrome-B(5) Reductase; Cytochromes b5; Dimyristoylphosphatidylcholine; Flufenamic Acid; Lipid Bilayers; NAD; NADP; Phosphatidylcholines; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins H

1982
Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
    Xenobiotica; the fate of foreign compounds in biological systems, 2000, Volume: 30, Issue:8

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Carcinogens; Cytosol; Enzyme Inhibitors; Female; Flufenamic Acid; Humans; Hydroxysteroid Dehydrogenases; Liver; Male; Medroxyprogesterone Acetate; Middle Aged; NAD; NADP; Nicotiana; Nitrosamines; Phenolphthalein; Plants, Toxic; Quercetin; Rutin; Smoke; Vitamin K

2000
Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action.
    The Journal of biological chemistry, 2004, Mar-12, Volume: 279, Issue:11

    Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Catalysis; Cell Line; Cytosol; DNA, Complementary; Flufenamic Acid; GABA Antagonists; Humans; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Models, Biological; Models, Molecular; NADP; Polymerase Chain Reaction; Protein Isoforms; Recombinant Proteins; RNA, Messenger; Software; Steroids; Time Factors

2004
Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenase.
    The Journal of biological chemistry, 2007, Mar-16, Volume: 282, Issue:11

    Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Amino Acid Sequence; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Flufenamic Acid; Humans; Hydrogen Bonding; Hydroxyprostaglandin Dehydrogenases; Molecular Conformation; Molecular Sequence Data; NADP; Protein Binding

2007